PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.
%A Sozio, Stephen M.; Coresh, Josef; Jaar, Bernard G.; Fink, Nancy E.; Plantinga, Laura C.; Armstrong, Paige A.; Longenecker, J. Craig; Sharrett, A. Richey; Powe, Neil R.; Parekh, Rulan S.
%T Inflammatory markers and risk of cerebrovascular events in patients initiating dialysis.
%J Clinical journal of the American Society of Nephrology : CJASN, vol. 6, no. 6, pp. 1292-1300
%D 06/2011
%V 6
%N 6
%M eng
%B Stroke remains a leading cause of morbidity and mortality for patients on dialysis; however, its risk factors in this population and measures to prevent it are not well understood.
%K Adult, Aged, Biomarkers, Cerebrovascular Disorders, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Incidence, Inflammation, Inflammation Mediators, Kidney Failure, Chronic, Linear Models, Male, Middle Aged, Nonlinear Dynamics, Proportional Hazards Models, Prospective Studies, Renal Dialysis, Risk Assessment, Risk Factors, Time Factors, Treatment Outcome, United States
%P 1292
%L 1300
%Y 10.2215/CJN.08350910
%W PHY
%G AUTHOR
%R 2011........6.1292S

@Article{Sozio2011,
author="Sozio, Stephen M.
and Coresh, Josef
and Jaar, Bernard G.
and Fink, Nancy E.
and Plantinga, Laura C.
and Armstrong, Paige A.
and Longenecker, J. Craig
and Sharrett, A. Richey
and Powe, Neil R.
and Parekh, Rulan S.",
title="Inflammatory markers and risk of cerebrovascular events in patients initiating dialysis.",
journal="Clinical journal of the American Society of Nephrology : CJASN",
year="2011",
month="Jun",
day="05",
volume="6",
number="6",
pages="1292--1300",
keywords="Adult",
keywords="Aged",
keywords="Biomarkers",
keywords="Cerebrovascular Disorders",
keywords="Female",
keywords="Humans",
keywords="Hydroxymethylglutaryl-CoA Reductase Inhibitors",
keywords="Incidence",
keywords="Inflammation",
keywords="Inflammation Mediators",
keywords="Kidney Failure, Chronic",
keywords="Linear Models",
keywords="Male",
keywords="Middle Aged",
keywords="Nonlinear Dynamics",
keywords="Proportional Hazards Models",
keywords="Prospective Studies",
keywords="Renal Dialysis",
keywords="Risk Assessment",
keywords="Risk Factors",
keywords="Time Factors",
keywords="Treatment Outcome",
keywords="United States",
abstract="Stroke remains a leading cause of morbidity and mortality for patients on dialysis; however, its risk factors in this population and measures to prevent it are not well understood.",
issn="1555-905X",
doi="10.2215/CJN.08350910",
url="http://www.ncbi.nlm.nih.gov/pubmed/21551022",
language="eng"
}

%0 Journal Article
%T Inflammatory markers and risk of cerebrovascular events in patients initiating dialysis.
%A Sozio, Stephen M.
%A Coresh, Josef
%A Jaar, Bernard G.
%A Fink, Nancy E.
%A Plantinga, Laura C.
%A Armstrong, Paige A.
%A Longenecker, J. Craig
%A Sharrett, A. Richey
%A Powe, Neil R.
%A Parekh, Rulan S.
%J Clinical journal of the American Society of Nephrology : CJASN
%D 2011
%8 Jun 05
%V 6
%N 6
%@ 1555-905X
%G eng
%F Sozio2011
%X Stroke remains a leading cause of morbidity and mortality for patients on dialysis; however, its risk factors in this population and measures to prevent it are not well understood.
%K Adult
%K Aged
%K Biomarkers
%K Cerebrovascular Disorders
%K Female
%K Humans
%K Hydroxymethylglutaryl-CoA Reductase Inhibitors
%K Incidence
%K Inflammation
%K Inflammation Mediators
%K Kidney Failure, Chronic
%K Linear Models
%K Male
%K Middle Aged
%K Nonlinear Dynamics
%K Proportional Hazards Models
%K Prospective Studies
%K Renal Dialysis
%K Risk Assessment
%K Risk Factors
%K Time Factors
%K Treatment Outcome
%K United States
%U http://dx.doi.org/10.2215/CJN.08350910
%U http://www.ncbi.nlm.nih.gov/pubmed/21551022
%P 1292-1300

PT Journal
AU Sozio, SM
   Coresh, J
   Jaar, BG
   Fink, NE
   Plantinga, LC
   Armstrong, PA
   Longenecker, JC
   Sharrett, AR
   Powe, NR
   Parekh, RS
TI Inflammatory markers and risk of cerebrovascular events in patients initiating dialysis.
SO Clinical journal of the American Society of Nephrology : CJASN
JI Clin J Am Soc Nephrol
PD Jun
PY 2011
BP 1292
EP 1300
VL 6
IS 6
DI 10.2215/CJN.08350910
LA eng
DE Adult; Aged; Biomarkers; Cerebrovascular Disorders; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Inflammation; Inflammation Mediators; Kidney Failure, Chronic; Linear Models; Male; Middle Aged; Nonlinear Dynamics; Proportional Hazards Models; Prospective Studies; Renal Dialysis; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; United States
AB Stroke remains a leading cause of morbidity and mortality for patients on dialysis; however, its risk factors in this population and measures to prevent it are not well understood.
ER

PMID- 21551022
OWN - NLM
STAT- MEDLINE
DA  - 20110609
DCOM- 20110930
LR  - 20151119
IS  - 1555-905X (Electronic)
IS  - 1555-9041 (Linking)
VI  - 6
IP  - 6
DP  - 2011 Jun
TI  - Inflammatory markers and risk of cerebrovascular events in patients initiating
      dialysis.
PG  - 1292-300
LID - 10.2215/CJN.08350910 [doi]
AB  - BACKGROUND AND OBJECTIVES: Stroke remains a leading cause of morbidity and
      mortality for patients on dialysis; however, its risk factors in this population 
      and measures to prevent it are not well understood. DESIGN, SETTING,
      PARTICIPANTS, & MEASUREMENTS: We investigated whether inflammation was associated
      with cerebrovascular events in a national US cohort of 1041 incident dialysis
      patients enrolled from October 1995 to June 1998 and followed until January 31,
      2004. Incident cerebrovascular events were defined as nonfatal (hospitalized
      stroke, carotid endarterectomy) and fatal (stroke death) events after dialysis
      initiation. With Cox proportional hazards regression analysis accounting for the 
      competing risk of nonstroke death, we assessed the independent event risk
      associated with baseline levels of multiple inflammatory markers
      (high-sensitivity C-reactive protein [hsCRP], interleukin-6 (IL-6), matrix
      metalloproteinase-3 [MMP-3], and P-selectin) and
      hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor (statin) use,
      which may have pleiotropic inflammatory effects. RESULTS: 165 patients
      experienced a cerebrovascular event during 3548 person-years of follow-up;
      overall incidence rate was 4.9/100 person-years. None of the inflammatory markers
      were associated with cerebrovascular event risk (adjusted hazard ratios [HRs] per
      log unit [95% confidence interval]: hsCRP, 0.97 [0.85 to 1.11]; IL-6, 1.04 [0.85 
      to 1.26]; MMP-3, 1.02 [0.70 to 1.48]; P-selectin, 0.98 [0.57 to 1.68]). Statin
      use was also not associated with significant risk of events in unadjusted (HR
      1.07 [0.69 to 1.68]) or propensity-score adjusted analyses (HR 0.98 [0.61 to
      1.56]). CONCLUSIONS: In conclusion, neither inflammatory markers nor statin use
      was associated with risk of cerebrovascular events. Further studies are needed to
      understand the pathophysiology and prevention of stroke in patients on dialysis.
FAU - Sozio, Stephen M
AU  - Sozio SM
AD  - Department of Medicine, Division of Nephrology, Johns Hopkins University School
      of Medicine, Baltimore, MD 21224, USA. [email protected]
FAU - Coresh, Josef
AU  - Coresh J
FAU - Jaar, Bernard G
AU  - Jaar BG
FAU - Fink, Nancy E
AU  - Fink NE
FAU - Plantinga, Laura C
AU  - Plantinga LC
FAU - Armstrong, Paige A
AU  - Armstrong PA
FAU - Longenecker, J Craig
AU  - Longenecker JC
FAU - Sharrett, A Richey
AU  - Sharrett AR
FAU - Powe, Neil R
AU  - Powe NR
FAU - Parekh, Rulan S
AU  - Parekh RS
LA  - eng
GR  - K24DK002643/DK/NIDDK NIH HHS/United States
GR  - KL2RR025006/RR/NCRR NIH HHS/United States
GR  - R01DK059616/DK/NIDDK NIH HHS/United States
GR  - R01DK072367/DK/NIDDK NIH HHS/United States
GR  - R01HL62985/HL/NHLBI NIH HHS/United States
GR  - R01HS008365/HS/AHRQ HHS/United States
GR  - R21DK067651/DK/NIDDK NIH HHS/United States
GR  - U01DK057304/DK/NIDDK NIH HHS/United States
GR  - U01DK067651/DK/NIDDK NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, P.H.S.
DEP - 20110505
PL  - United States
TA  - Clin J Am Soc Nephrol
JT  - Clinical journal of the American Society of Nephrology : CJASN
JID - 101271570
RN  - 0 (Biomarkers)
RN  - 0 (Hydroxymethylglutaryl-CoA Reductase Inhibitors)
RN  - 0 (Inflammation Mediators)
SB  - IM
MH  - Adult
MH  - Aged
MH  - Biomarkers/blood
MH  - Cerebrovascular Disorders/*etiology/immunology/mortality
MH  - Female
MH  - Humans
MH  - Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use
MH  - Incidence
MH  - Inflammation/*etiology/immunology/mortality
MH  - Inflammation Mediators/*blood
MH  - Kidney Failure, Chronic/complications/immunology/mortality/*therapy
MH  - Linear Models
MH  - Male
MH  - Middle Aged
MH  - Nonlinear Dynamics
MH  - Proportional Hazards Models
MH  - Prospective Studies
MH  - Renal Dialysis/*adverse effects/mortality
MH  - Risk Assessment
MH  - Risk Factors
MH  - Time Factors
MH  - Treatment Outcome
MH  - United States
PMC - PMC3109924
OID - NLM: PMC3109924
EDAT- 2011/05/10 06:00
MHDA- 2011/10/01 06:00
CRDT- 2011/05/10 06:00
PHST- 2011/05/05 [aheadofprint]
AID - CJN.08350910 [pii]
AID - 10.2215/CJN.08350910 [doi]
PST - ppublish
SO  - Clin J Am Soc Nephrol. 2011 Jun;6(6):1292-300. doi: 10.2215/CJN.08350910. Epub
      2011 May 5.
TY  - JOUR
AU  - Sozio, Stephen M.
AU  - Coresh, Josef
AU  - Jaar, Bernard G.
AU  - Fink, Nancy E.
AU  - Plantinga, Laura C.
AU  - Armstrong, Paige A.
AU  - Longenecker, J. Craig
AU  - Sharrett, A. Richey
AU  - Powe, Neil R.
AU  - Parekh, Rulan S.
PY  - 2011/Jun/05
TI  - Inflammatory markers and risk of cerebrovascular events in patients initiating dialysis.
T2  - Clin J Am Soc Nephrol
JO  - Clinical journal of the American Society of Nephrology : CJASN
SP  - 1292
EP  - 1300
VL  - 6
IS  - 6
KW  - Adult
KW  - Aged
KW  - Biomarkers
KW  - Cerebrovascular Disorders
KW  - Female
KW  - Humans
KW  - Hydroxymethylglutaryl-CoA Reductase Inhibitors
KW  - Incidence
KW  - Inflammation
KW  - Inflammation Mediators
KW  - Kidney Failure, Chronic
KW  - Linear Models
KW  - Male
KW  - Middle Aged
KW  - Nonlinear Dynamics
KW  - Proportional Hazards Models
KW  - Prospective Studies
KW  - Renal Dialysis
KW  - Risk Assessment
KW  - Risk Factors
KW  - Time Factors
KW  - Treatment Outcome
KW  - United States
N2  - Stroke remains a leading cause of morbidity and mortality for patients on dialysis; however, its risk factors in this population and measures to prevent it are not well understood.
SN  - 1555-905X
UR  - http://dx.doi.org/10.2215/CJN.08350910
UR  - http://www.ncbi.nlm.nih.gov/pubmed/21551022
ID  - Sozio2011
ER  - 
<?xml version="1.0" encoding="UTF-8"?>
<b:Sources SelectedStyle="" xmlns:b="http://schemas.openxmlformats.org/officeDocument/2006/bibliography"  xmlns="http://schemas.openxmlformats.org/officeDocument/2006/bibliography" >
<b:Source>
<b:Tag>Sozio2011</b:Tag>
<b:SourceType>ArticleInAPeriodical</b:SourceType>
<b:Year>2011</b:Year>
<b:Month>Jun</b:Month>
<b:Day>05</b:Day>
<b:PeriodicalName>Clinical journal of the American Society of Nephrology : CJASN</b:PeriodicalName>
<b:Volume>6</b:Volume>
<b:Issue>6</b:Issue>
<b:Pages>1292-1300</b:Pages>
<b:Author>
<b:Author><b:NameList>
<b:Person><b:Last>Sozio</b:Last><b:First>Stephen</b:First><b:Middle>M</b:Middle></b:Person>
<b:Person><b:Last>Coresh</b:Last><b:First>Josef</b:First></b:Person>
<b:Person><b:Last>Jaar</b:Last><b:First>Bernard</b:First><b:Middle>G</b:Middle></b:Person>
<b:Person><b:Last>Fink</b:Last><b:First>Nancy</b:First><b:Middle>E</b:Middle></b:Person>
<b:Person><b:Last>Plantinga</b:Last><b:First>Laura</b:First><b:Middle>C</b:Middle></b:Person>
<b:Person><b:Last>Armstrong</b:Last><b:First>Paige</b:First><b:Middle>A</b:Middle></b:Person>
<b:Person><b:Last>Longenecker</b:Last><b:First>J</b:First><b:Middle>Craig</b:Middle></b:Person>
<b:Person><b:Last>Sharrett</b:Last><b:First>A</b:First><b:Middle>Richey</b:Middle></b:Person>
<b:Person><b:Last>Powe</b:Last><b:First>Neil</b:First><b:Middle>R</b:Middle></b:Person>
<b:Person><b:Last>Parekh</b:Last><b:First>Rulan</b:First><b:Middle>S</b:Middle></b:Person>
</b:NameList></b:Author>
</b:Author>
<b:Title>Inflammatory markers and risk of cerebrovascular events in patients initiating dialysis.</b:Title>
 <b:ShortTitle>Clin J Am Soc Nephrol</b:ShortTitle>
<b:Comments>Stroke remains a leading cause of morbidity and mortality for patients on dialysis; however, its risk factors in this population and measures to prevent it are not well understood.</b:Comments>
</b:Source>
</b:Sources>